Altria: Will Outsmart the FDA

9/21/17

Altria (MO) faces many headwinds going forward, but the negativity encompassing this sector has left the stock undervalued. This article explains some history of the events that caused the recent stock price decline, and the reasons I think Altria can overcome these challenges. The company can’t adjust the winds of change that effect the tobacco industry - but they can adjust their sails to put the wind at their backs.

Fundamentals

Currently, Altria is yielding (fwd) 4.17% and has had 50 dividend increasesover the last 47 years. The dividend growth rate over the last 5 years has been 8.71%. A recent dividend raise of 8.2% on August 24th, along with a reaffirmation of 2017 earnings on September 5th at the Barclays Global Consumer Conference confirms Altria is on track to continue the streak of dividend raises.

READ FULL ARTICLE HERE

Recent Deals

Interested in advertising your deals? Contact Edwin Warfield.